Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "NIT"

6211 News Found

NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate
Drug Approval | April 15, 2023

NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate

Study efficacy measures will include the expression of dystrophin protein and motor function.


Digital Health: An opportunity to increase health equity
Digitisation | April 14, 2023

Digital Health: An opportunity to increase health equity

Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%


Philips and Northwell Health partner to standardize patient monitoring across the enterprise
News | April 05, 2023

Philips and Northwell Health partner to standardize patient monitoring across the enterprise

New York State’s largest health system adopts Philips patient monitoring platform to drive integration and innovation for a better patient and staff experience and improved outcomes


HSBC acquisition of SVB UK to unleash new opportunities in biotech sector, finds GlobalData
Biotech | April 01, 2023

HSBC acquisition of SVB UK to unleash new opportunities in biotech sector, finds GlobalData

SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development


Vijaya Medical and Educational Trust, Vadapalani  adopts AI-based monitoring technology
Digitisation | March 29, 2023

Vijaya Medical and Educational Trust, Vadapalani adopts AI-based monitoring technology

Vijaya Hospital, Chennai adopted Dozee’s AI-based contactless continuous remotemonitoring and early warning system to enhance patient safety


Bliss GVS Pharma gets 3 minor observations from USFDA for Palghar unit
Drug Approval | March 19, 2023

Bliss GVS Pharma gets 3 minor observations from USFDA for Palghar unit

The observations are procedural in nature


Aster DM Healthcare appoints Dr. Nitish Shetty as India CEO
People | March 18, 2023

Aster DM Healthcare appoints Dr. Nitish Shetty as India CEO

He is Proficient in overseeing and leading teams for running successful business operations


Cepheid launches its first manufacturing unit in India
News | March 15, 2023

Cepheid launches its first manufacturing unit in India

The facility has been set up to manufacture tuberculosis testing cartridges


Shilpa Medicare gets 2 minor observations from USFDA for Unit VII, Analytical Services Division
Drug Approval | March 13, 2023

Shilpa Medicare gets 2 minor observations from USFDA for Unit VII, Analytical Services Division

The company will be submitting the responses to US FDA observations within stipulated timeline


Apollo partners with LifeSigns to donate 1000 remote patient monitoring patches to Turkey
News | March 07, 2023

Apollo partners with LifeSigns to donate 1000 remote patient monitoring patches to Turkey

These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.